相似文献
1
Psychosis and enhanced anxiety produced by reserpine and chlorpromazine.
Can Med Assoc J. 1956 Apr 1;74(7):526-32.
2
Psychosis apparently produced by reserpine.
J Am Med Assoc. 1955 Oct 29;159(9):839-40. doi: 10.1001/jama.1955.02960260009003.
3
Treatment of hypertensive patients with Rauwolfia compounds and reserpine; depressive and psychotic changes.
J Am Med Assoc. 1955 Dec 17;159(16):1513-6. doi: 10.1001/jama.1955.02960330013004.
4
[Danger of associated reserpine and electroshock; akathisia appearing during neuroleptic treatment].
Ann Med Psychol (Paris). 1956 Jul;114(2):327-31.
5
The major complications of treatment of psychotic states with chlorpromazine and reserpine and their management.
Psychiatr Res Rep Am Psychiatr Assoc. 1956 Apr(4):79-88.
6
Clinical investigation of chlorpromazine and reserpine in private psychiatric practice.
Am J Psychiatry. 1956 Apr;112(10):782-7. doi: 10.1176/ajp.112.10.782.
7
Agranulocytosis while receiving combined reserpine-chlorpromazine therapy; report of two cases.
Dis Nerv Syst. 1956 Mar;17(3):88-90.
8
Parkinsonian reactions following chlorpromazine and reserpine; similar reactions in the same patients.
AMA Arch Neurol Psychiatry. 1956 May;75(5):522-4. doi: 10.1001/archneurpsyc.1956.02330230072008.
9
[Psychiatric experiences with megaphen (largactil) and the Rauwolfia alkaloid serpasil with special reference to Parkinson's psychomotor syndrome].
Nervenarzt. 1955 Dec 20;26(12):507-10.
10
Chlorpromazine and reserpine in the treatment of psychoses.
Ann N Y Acad Sci. 1955 Apr 15;61(1):174-82. doi: 10.1111/j.1749-6632.1955.tb42464.x.
引用本文的文献
1
Drug-drug interactions involving classic psychedelics: A systematic review.
J Psychopharmacol. 2024 Jan;38(1):3-18. doi: 10.1177/02698811231211219. Epub 2023 Nov 20.
2
Witches, potions, and metabolites: an overview from a medicinal perspective.
RSC Med Chem. 2022 Mar 30;13(4):405-412. doi: 10.1039/d2md00025c. eCollection 2022 Apr 20.
3
Serotonergic Neurotransmission System Modulator, Vortioxetine, and Dopaminergic D/D Receptor Agonist, Ropinirole, Attenuate Fibromyalgia-Like Symptoms in Mice.
Molecules. 2021 Apr 20;26(8):2398. doi: 10.3390/molecules26082398.
4
Behavioral effects of bidirectional modulators of brain monoamines reserpine and d-amphetamine in zebrafish.
Brain Res. 2013 Aug 21;1527:108-16. doi: 10.1016/j.brainres.2013.06.033. Epub 2013 Jul 1.
5
A methodology of testing, and clinical applications of, the neuroleptic drugs in psychiatry.
Psychiatr Q. 1960 Jan;34:24-46. doi: 10.1007/BF01675225.
6
Clinical investigation of trifluoperazine (stelazine) in open psychiatric settings.
Can Med Assoc J. 1959 Nov 1;81(9):717-23.
7
On the psychology of the shaking palsy.
Psychiatr Q. 1962 Apr;36:203-21. doi: 10.1007/BF01586113.
8
Paradoxical reactions to benzodiazepines.
Br J Clin Pharmacol. 1981;11 Suppl 1(Suppl 1):99S-104S. doi: 10.1111/j.1365-2125.1981.tb01844.x.
本文引用的文献
1
Clinical uses of rauwolfia. I. In arterial hypertension.
Can Med Assoc J. 1955 Apr 1;72(7):483-9.
2
Oral preparations of Reuwolfia serpentina in treatment of essential hypertension.
Br Med J. 1955 Apr 2;1(4917):809-16. doi: 10.1136/bmj.1.4917.809.
3
Psychodynamic aspects of reserpine: its uses and effects in open psychiatric settings.
Can Psychiatr Assoc J. 1956 Jan;1(1):11-7. doi: 10.1177/070674375600100103.
4
Hypertension treated with Rauwolfia serpentina (whole root) and with reserpine; controlled study disclosing occasional severe depression.
J Am Med Assoc. 1955 Oct 29;159(9):841-5. doi: 10.1001/jama.1955.02960260011004.
5
Psychosis apparently produced by reserpine.
J Am Med Assoc. 1955 Oct 29;159(9):839-40. doi: 10.1001/jama.1955.02960260009003.
6
Depression and anxiety occurring during Rauwolfia therapy.
J Am Med Assoc. 1955 Oct 29;159(9):836-9. doi: 10.1001/jama.1955.02960260006002.
7
The use of reserpine in an open psychiatric setting.
Can Med Assoc J. 1955 Aug 1;73(3):187-91.
8
Mental depression in hypertensive patients treated for long periods with large doses of reserpine.
N Engl J Med. 1954 Dec 16;251(25):1006-8. doi: 10.1056/NEJM195412162512504.
Zotero 插件